About JW Therapeutics
JW Therapeutics is a company based in Shanghai (China) founded in 2016 by James Li.. JW Therapeutics has raised $195.55 million across 2 funding rounds from investors including Juno Therapeutics, Mirae Asset and WuXi AppTec. The company has 281 employees as of December 31, 2024. JW Therapeutics operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others.
- Headquarter Shanghai, China
- Employees 281 as on 31 Dec, 2024
- Founders James Li
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Jw (Cayman) Therapeutics Co. Ltd.
-
Annual Revenue
$22.09 M (USD)-10.71as on Dec 31, 2024
-
Net Profit
$-82.45 M (USD)24.54as on Dec 31, 2024
-
EBITDA
$-54.29 M (USD)20.67as on Dec 31, 2024
-
Total Equity Funding
$195.55 M (USD)
in 2 rounds
-
Latest Funding Round
$105.55 M (USD), Series B
Jun 30, 2020
-
Investors
Juno Therapeutics
& 14 more
-
Employee Count
281
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of JW Therapeutics
JW Therapeutics is a publicly listed company on the HKEX with ticker symbol 2126 in Hong Kong, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Funding Insights of JW Therapeutics
JW Therapeutics has successfully raised a total of $195.55M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $105.55 million completed in June 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $105.5M
-
First Round
First Round
(07 Mar 2018)
- Investors Count 15
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2020 | Amount | Series B - JW Therapeutics | Valuation | Mirae Asset , CR Capital Management | |
| Mar, 2018 | Amount | Series A - JW Therapeutics | Valuation | Temasek , Sequoia Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in JW Therapeutics
JW Therapeutics has secured backing from 15 investors, including institutional and venture fund investors. Prominent investors backing the company include Juno Therapeutics, Mirae Asset and WuXi AppTec. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Venture capital, equity investment, and fund management services in China.
|
Founded Year | Domain | Location | |
|
An investment platform is provided for diverse sectors and geographies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by JW Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - JW Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Jw Therapeutics Comparisons
Competitors of JW Therapeutics
JW Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Jw Therapeutics
Frequently Asked Questions about JW Therapeutics
When was JW Therapeutics founded?
JW Therapeutics was founded in 2016 and raised its 1st funding round 2 years after it was founded.
Where is JW Therapeutics located?
JW Therapeutics is headquartered in Shanghai, China.
Who is the current CEO of JW Therapeutics?
James Li is the current CEO of JW Therapeutics. They have also founded this company.
Is JW Therapeutics a funded company?
JW Therapeutics is a funded company, having raised a total of $195.55M across 2 funding rounds to date. The company's 1st funding round was a Series A of $90M, raised on Mar 07, 2018.
How many employees does JW Therapeutics have?
As of Dec 31, 2024, the latest employee count at JW Therapeutics is 281.
What is the annual revenue of JW Therapeutics?
Annual revenue of JW Therapeutics is $22.09M as on Dec 31, 2024.
What does JW Therapeutics do?
JW Therapeutics was founded in 2016 and is headquartered in Shanghai, China. Focus is placed on the development of cell immunotherapy products targeting cancer. The pipeline encompasses JWCAR029 and JWCAR129 for hematologic malignancies, along with Nex-G, while JWATM203 and JWATM204 address solid tumors. Operations center on advancing these therapies within the biotechnology sector.
Who are the top competitors of JW Therapeutics?
JW Therapeutics's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
Is JW Therapeutics publicly traded?
Yes, JW Therapeutics is publicly traded on HKEX under the ticker symbol 2126.
Who are JW Therapeutics's investors?
JW Therapeutics has 15 investors. Key investors include Juno Therapeutics, Mirae Asset, WuXi AppTec, Temasek, and Arch Venture Partners.
What is JW Therapeutics's ticker symbol?
The ticker symbol of JW Therapeutics is 2126 on HKEX.